FCS establishes subsidiary Vita Nova Insights for healthcare analytics
Florida Most cancers Specialists & Analysis Institute (FCS), an unbiased medical oncology/hematology follow in Florida, has launched a healthcare analytics subsidiary referred to as Vita Nova Insights.
The subsidiary is wholly owned by FCS's administration providers group, Neighborhood Oncology Revitalization Enterprise (Core Ventures).
It’s devoted to offering correct oncology insights and real-world proof to enhance most cancers analysis and therapy.
Over the previous 12 months, Vita Nova Insights has performed a number of real-world proof research in collaboration with main pharmaceutical corporations around the globe.
The subsidiary's reference to FCS physicians permits them to shortly determine and tackle therapeutic challenges to enhance affected person outcomes.
Vita Nova Insights, in collaboration with FCS, offers physicians and medical researchers entry to FCS' numerous vary of information property.
Acquire entry to essentially the most complete firm profiles in the marketplace, powered by GlobalData. Save hours of analysis. Acquire aggressive benefit.
Firm Profile – Free Pattern
Your obtain electronic mail will arrive shortly
Now we have confidence within the distinctive high quality of our firm profiles. Nonetheless, we would like you to take advantage of helpful choice for your small business. That's why we give you a free pattern you can obtain by submitting the shape under.
By GlobalData
These property embrace follow administration techniques and digital well being information (EMRs), in addition to radiation, radiology, genomics, pharmacy and laboratory information.
The info is standardized and enriched with exterior sources to offer a complete overview of affected person well being.
Vita Nova Insights combines synthetic intelligence know-how and information science with its medical oncology experience to create insights that assist medical analysis, optimize affected person care, and switch FCS real-world information into helpful proof for the event and discovery of recent therapies.
The brand new subsidiary may also present FCS physicians with analytical insights into next-generation sequencing checks being carried out within the subject.
That is made doable by the corporate's inner MolecularHelp service, which is powered by the FCS PRECISE precision oncology platform.
FCS senior vice chairman and information officer Trevor Heritage mentioned: “Given the tempo of innovation in precision oncology, with new therapies coming to market at an unprecedented tempo, it’s difficult for physicians to maintain up.
“Vita Nova Insights analyzes every genomics check consequence, within the context of the affected person's whole medical report, and alerts physicians in actual time to corresponding therapy choices and related proof.”
